Hide Notes 

Slide 1: Personalized Medicine Market Worldwide (2010 – 2015) - By Segments, Technologies, Opportunities, Challenges & Future Forecast Published: February, 2011 Publisher: Renub Research (www.renub.com)
Slide 2: Report Details Renub Research report titled “Personalized Medicine Market Worldwide (2010 – 2015) - By Segments, Technologies, Opportunities, Challenges & Future Forecast” analysis the global personalized medicine. This research report provides the global personalized medicine sector perspective from past trends to future scenario (2006 to 2015). Personalized medicine segments like Genetically Modified (GM) Products, Wellness & Disease Management, Targeted Biologics, Other Molecular Diagnostics, Genomics and Proteomics and Consumer Self Diagnostic markets data from 2006 to 2015 has been analyzed in this report. From technology point of view segments like Molecular Diagnostics, Biochips, Pharmacogenomics, SNP Genotyping, Pharmacogenetics, Point of Care Testing, Genetic Screening and Pharmacoproteomics markets data from (2007 to 2014) has been provided in the report. Report reviews the competitive dynamic of mergers and acquisitions in the personalized medicine market. The report also provides valuable insight on the growth driver within the global personalized medicine market and challenges faced in the global personalized medicine market. Personalized Medicine Market Overview Personalized Medicine is often defined as “the right treatment for the right person at the right time.” While the market for diagnostic tests and therapies that leverage this new science is growing, the biggest opportunities exist outside of the traditional healthcare sector. The Personalized Medicine market is projected to grow 11.56 percent annually and expected to reach US$ 148.4 Billion by 2015. The fastest growth is expected to come from proteomics & genomics segment as extensive research in genomics and proteomics is promising cures for disease which were previously untreatable. Drug discovery companies are also likely to have ample opportunities to slightly modify the lead compound in order to screen and exclude patients of a certain genotype who are more prone to developing certain side effects from clinical trials. Targeted Biologics is one of the most exciting areas of therapeutic medicine and may represent about one in every four newly commercialized drugs in the future. Targeted Biologics is the largest segment in the personalized medicine market and forecasted to grow steadily with the compound annual
Slide 3: growth rate of 10 percent annually. Targeted Biologics gives immense hope for the companies to cope up with the challenges in the Personalized Medicine Market. By the prolific segmentation of the market, this market has shown bigger platform for the player who is in the category for the development of personalized medicine. The pharmacogenomics and pharmacogenetics have had provided exceptionally highly demonstrated platform for the personalized medicine to ignite the substantial growth in the personalized medicine diagnostic product by technology. Affymetrix Inc, HistoRx, Qiagen, Illumina Inc, Hologic Inc are the key players in the personalized medicine market. However, their leadership is likely to be challenged by the emergence of a new breed of players who is working in this segment. Research Highlights      Proteomics & Genomics market is expected to be over US$ 30 Billion by 2015. Targeted Biologics is the largest segment in the personalized medicine market and it is growing steadily with the compound annual growth rate of 10 percent. Targeted Biologics and Proteomics & Genomics together controls 57% of market share in 2010 Point of care diagnostics market share is expected to reduce to 36% from 42% in 2010 Molecular Diagnostics is expected to have the second highest market share after point of care diagnostics Key Company Profiles This section provides business overview and key financial information of the companies listed below: Affymetrix Inc., HistoRx, Qiagen, Illumina, Inc, Third Wave Technologies, Inc, Hologic, Inc. © Renub Research Page 3 of 14
Slide 4: Data Sources Information and data in this report has been collected from various printable and nonprintable sources like Trade Journals, White papers, Online paid databases, News websites, Government Agencies, Magazines, Newspapers and Trade associations. © Renub Research Page 4 of 14
Slide 5: Published By Renub Research A–116B, Sector–27 Noida – 201301 Phone: +91-120-421-9822, 254-5750 (India) +1-678-302-0700 (USA) Fax : +91-120-424-9780 Email: info@renub.com www.renub.com © Personalized Medicine Market Worldwide (2010 – 2015) - By Segments, Technologies, Opportunities, Challenges & Future Forecast Renub Research, 2011 Edition 1.0 All rights reserved. This publication is protected by copyright. No part of it may be reproduced, stored in a retrieval system or transmitted, in any form or by any means, electronic mechanical, photocopying, recording or otherwise without the prior written permission of the publishers © Renub Research Page 5 of 14
Slide 6: Table of Contents 1. 2. Executive Summary Era of Personalized Medicine: Emerging Products 2.1 2.2 3. Personalized Medicine: The New Science The Promise of Personalized Medicine The Personalized Medicine Business Landscape 3.1 A Complex Ecosystem of Companies Therapeutics Diagnostics Theranostics (Companion Medicine) 3.1.1 3.1.2 3.1.3 4. Worldwide – Personalized Medicine Market, Future Forecast & Market Share 4.1 4.2 2015) 4.3 By Technology – Personalized Medicine Diagnostic Market Share & Future Forecast Worldwide Worldwide – Personalized Medicine Market & Future Forecast (2006 – 2015) By Segments – Personalized Medicine Market Share & Future Forecast Worldwide (2006 – (2007 – 2014) 5. By Segment – Personalized Medicine Market (from 2006 to 2015) 5.1 5.2 5.3 5.4 5.5 5.6 6. Genetically Modified (GM) Products Market & Future Forecast Wellness & Disease Management Market & Future Forecast Consumer Self-Diagnostic Market & Future Forecast Other Molecular Diagnostics Market & Future Forecast Proteomics & Genomics Market & Future Forecast Targeted Biologics Market & Future Forecast Worldwide (By Technology) – Personalized Medicine Diagnostic Product Market & Future Forecast (from 2005 to 2015) 6.1 6.2 6.3 6.4 Molecular Diagnostics Market & Future Forecast Pharmacogenomics Market & Future Forecast SNP Genotyping Market & Future Forecast Pharmacogenetics Market & Future Forecast Page 6 of 14 © Renub Research
Slide 7: 6.5 6.6 6.7 6.8 7. Pharmacoproteomics Market & Future Forecast Biochips Market & Future Forecast Point of Care Testing Market & Future Forecast Genetic Screening Market & Future Forecast Key Drivers (Opportunities) of Growth in Personalized Medicine Market 7.1 7.2 7.3 Government Agencies Shaping Personalized Medicine Organizations will Profit Together, Not Alone in the Personalized Medicine The Blockbuster Model of One Drug Fits all is under Pressure 8. Challenges 8.1 8.2 Reimbursement Policy & Regulatory Framework Payers Worry That Cost of Personalized Medicine Could Be Unsustainable 9. 10. Merger & Acquisition Key Players Affymetrix Inc. Qiagen Illumina Inc. Hologic Inc 10.1 10.2 10.3 10.4 © Renub Research Page 7 of 14
Slide 8: List of Figures: Figure 4-1: Worldwide – Personalized Medicine Market (Billion US$) 2006 – 2010 Figure 4-2: Worldwide – Future Forecast for Personalized Medicine Market (Billion US$) 2011 – 2015 Figure 4-3: Worldwide – Segments of Personalized Medicine Market Share (Percent), 2006 – 2010 Figure 4-4: Worldwide – Future Forecast for Segments of Personalized Medicine Market Share (Percent), 2011 – 2015 Figure 4-5: Worldwide – Personalized Medicine Diagnostic Product Market Share (Percent), 2007 – 2010 Figure 4-6: Worldwide – Future Forecast for Personalized Medicine Diagnostic Product Market Share (Percent), 2011 – 2014 Figure 5-1: Worldwide – Personalized GM Products Market (Billion US$) 2006 – 2010 Figure 5-2: Worldwide – Future Forecast for Personalized GM Products Market (Billion US$) 2011 – 2015 Figure 5-3: Worldwide – Personalized Wellness & Disease Management Market (Billion US$) 2006 – 2010 Figure 5-4: Worldwide – Future Forecast for Personalized Wellness & Disease Management Market (Billion US$) 2011 – 2015 Figure 5-5: Worldwide – Personalized Consumer Self-Diagnostic Market (Billion US$) 2006 – 2010 Figure 5-6: Worldwide – Future Forecast for Personalized Consumer Self-Diagnostic Market (Billion US$) 2011 – 2015 Figure 5-7: Worldwide – Other Molecular Diagnostics Market (Billion US$) 2006 – 2010 Figure 5-8: Worldwide – Future Forecast for Other Molecular Diagnostics Market (Billion US$) 2011 – 2015 Figure 5-9: Worldwide – Personalized Medicine Proteomics & Genomics Market (Billion US$) 2006 – 2010 Figure 5-10: Worldwide – Future Forecast for Personalized Medicine Proteomics & Genomics Market (Billion US$) 2011 – 2015 Figure 5-11: Worldwide – Targeted Biologics Market (Billion US$) 2006 – 2010 Figure 5-12: Worldwide – Future Forecast for Targeted Biologics Market (Billion US$) 2011 – 2015 Figure 6-1: Worldwide – Molecular Diagnostics Market (Billion US$), 2007 – 2009 Figure 6-2: Worldwide – Future Forecast for Molecular Diagnostics Market (Billion US$), 2010 – 2014 Figure 6-3: United States – Molecular Diagnostics Market (Million US$), 2002 – 2010 Figure 6-4: United States – Future Forecast for Molecular Diagnostics Market (Million US$), 2010 – 2014 Figure 6-5: Worldwide – Pharmacogenomics Market (Billion US$), 2005 – 2010 Figure 6-6: Worldwide – Future Forecast for Pharmacogenomics Market (Billion US$), 2011 – 2015 Figure 6-7: Worldwide – SNP Genotyping Market (Billion US$), 2005 – 2010 Figure 6-8: Worldwide – Future Forecast for SNP Genotyping Market (Billion US$), 2011 – 2015 Figure 6-9: Worldwide – Pharmacogenetics Market (Billion US$), 2005 – 2010 © Renub Research Page 8 of 14
Slide 9: Figure 6-10: Worldwide – Future Forecast for Pharmacogenetics Market (Billion US$), 2011 – 2015 Figure 6-11: Worldwide – Pharmacoproteomics Market (Billion US$), 2005 – 2010 Figure 6-12: Worldwide – Future Forecast for Pharmacoproteomics Market (Billion US$), 2011 – 2015 Figure 6-13: Worldwide – Biochips Market (Billion US$), 2005 – 2010 Figure 6-14: Worldwide – Future Forecast for Biochips Market (Billion US$), 2011 – 2015 Figure 6-15: Worldwide – Point of Care Testing Market (Billion US$), 2003, 2006 – 2010 Figure 6-16: Worldwide – Future Forecast for Point of Care Testing Market (Billion US$), 2011 – 2014 Figure 6-17: Worldwide – Genetic Screening Market (Billion US$), 2005 – 2010 Figure 6-18: Worldwide – Future Forecast for Genetic Screening Market (Billion US$), 2011 – 2015 © Renub Research Page 9 of 14
Slide 10: List of Tables: Table 9-1: Worldwide – Merger & Acquisition in Personalized Medicine (Billion US$), 2007 Table 9-2: Worldwide – M&A Deals in the IVD Sector with a Personalised Medicine Theme (Million, US$), 2009 Table 10-1: Affymetrix – Financials (Million US$) 2007 – 2009 Table 10-2: Qiagen – Financials (Million US$) 2007 – 2009 Table 10-3: Illumina Inc – Financial (Million US$) 2007 – 2009 Table 10-4: Hologic Inc – Financials (Million US$) 2007 – 2009 © Renub Research Page 10 of 14
Slide 11: Order Form Scan and e-mail this page to info@renub.com, alternatively one can also write the Contact Information in an e-mail and mail it. Else you can also fax this form to +91-120-424-9780 Questions? Please call +91-120-421-9822 (India), +1-678-302-0700 (USA) or mail to info@renub.com Format Report Title: Personalized Medicine Market Worldwide (2010 – 2015) - By Segments, Technologies, Opportunities, Challenges & Future Forecast Single User (Email from Publisher) US$ 1,100 Hard Copy (Mail Delivery) US$ 1,200 CD – Rom (Mail Delivery) US$ 1,200 Global Site License (Multiple User License) US$ 1,700 For ordering this report: Three easy ways to place your order: 1) Order online by Credit Card (Visa, MasterCard, etc.): http://renub.com/reports/showdetails.aspx?id=35 2) Order by Wire Transfer: http://renub.com/reports/wiretransfer.aspx?id=35&pid=1118 To pay by Wire Transfer, please, fill in your contact details in the form below: © Renub Research Page 11 of 14
Slide 12: Bank Details Account Name: Renub Research A/C No.: 109102000023296 Name of Bank: IDBI Bank Ltd. Swift Code: IBKLINBB010 Bank Address: 4th Floor Indian Red Cross Building 1 Red Cross Road Opposite Parliament Street New Delhi – 110001 India Contact Information First Name: Email: Job Title: Company: Address: City: Postal/Zip Code: Country: Phone: Mobile: Fax: Report Format: Your message: Last Name: © Renub Research Page 12 of 14
Slide 13: 3) Order by Check Please post the check accompanied by this form, to: Company Address: Renub Research A -116B Sector -27 Noida - 201301 Uttar Pradesh India Phone: +91-120-421-9822, 424-9780 For free Sample copy report or to view any of our sample work please contact us at info@renub.com or call +91-120-421-9822 (India), +1-678-302-0700 (USA) Follow Us Facebook: http://www.facebook.com/pages/Renub-Research/233380966701090 LinkedIn: http://www.linkedin.com/company/renub-research © Renub Research Page 13 of 14
Slide 14: About Us Renub Research in international is a leading Market Research and Information Analysis Company with centers at Noida India and Roswell USA. We have more than 7 years of experience especially Business-to-Business Researches, Surveys, Business and Consulting. Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others. Our core team is comprised of an experienced people holding graduate, post graduate and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research help make the business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today’s ultra-competitive markets. © Renub Research Page 14 of 14